CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 48 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -94.1% | 29,000 | -86.0% | 0.00% | -100.0% |
| Q1 2022 | $169,000 | -29.0% | 206,419 | -1.1% | 0.00% | -50.0% |
| Q4 2021 | $238,000 | -47.0% | 208,680 | +16.1% | 0.01% | -25.0% |
| Q3 2021 | $449,000 | +515.1% | 179,680 | +768.0% | 0.01% | +700.0% |
| Q1 2021 | $73,000 | -34.8% | 20,700 | -12.5% | 0.00% | -50.0% |
| Q4 2020 | $112,000 | -65.2% | 23,655 | -64.3% | 0.00% | -80.0% |
| Q3 2020 | $322,000 | +250.0% | 66,242 | +134.9% | 0.01% | +150.0% |
| Q2 2020 | $92,000 | – | 28,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |